Table 1.
Demographic characteristics and risk factors identification of patients
| HTPR (n=374) (30.2%) | Controls (n=864) (69.8%) | P | |
|---|---|---|---|
| Age, years | 58.03±11.88 | 58.05±11.72 | 0.971 |
| Female gender, (%) | 134/350 (38.3) | 216/350 (61.7) | 0.001 |
| Male gender, (%) | 240/888 (27) | 648/888 (73) | |
| Hypertension, (%) | 216 (57.7) | 421 (48.7) | 0.004 |
| Diabetes mellitus, (%) | 131 (35) | 252 (29.1) | 0.040 |
| Acute coronary syndrome, (%) | 232 (62) | 458 (53) | 0.010 |
| Stable angina pectoris, (%) | 142 (37.9) | 406 (46.9) | 0.010 |
| Tirofiban, (%) | 71 (18.9) | 260 (30) | 0.010 |
| Stent thrombosis, (%) | 11 (2.9) | 23 (2.6) | 0.820 |
| Cardiovascular mortality, (%) | 11 (2.9) | 35 (4) | 0.340 |
HTPR - high on-treatment platelet reactivity of clopidogrel